Eucrates Biomedical Acquisition Corp. (EUCR)
NASDAQ: EUCR · IEX Real-Time Price · USD
10.02
0.00 (0.00%)
Jan 26, 2023, 4:00 PM EST - Market closed
Total Valuation
EUCR has a market cap or net worth of $42.14 million. The enterprise value is $42.15 million.
Market Cap | 42.14M |
Enterprise Value | 42.15M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
EUCR has 4.21 million shares outstanding.
Shares Outstanding | 4.21M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 62.29% |
Owned by Institutions (%) | 186.59% |
Float | 2.76M |
Valuation Ratios
The trailing PE ratio is 55.67.
PE Ratio | 55.67 |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 16.68 |
EV / Sales | n/a |
EV / EBITDA | 16.68 |
EV / EBIT | 16.68 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81
Current Ratio | 0.81 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | 0.02 |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -58.80% and return on invested capital (ROIC) is 2.40%.
Return on Equity (ROE) | -58.80% |
Return on Assets (ROA) | 2.40% |
Return on Capital (ROIC) | 2.40% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.56% in the last 52 weeks. The beta is -0.09, so EUCR's price volatility has been lower than the market average.
Beta (1Y) | -0.09 |
52-Week Price Change | +2.56% |
50-Day Moving Average | 9.97 |
200-Day Moving Average | 9.95 |
Average Volume (30 Days) | 1,062 |
Short Selling Information
The latest short interest is 2,050, so 0.05% of the outstanding shares have been sold short.
Short Interest | 2,050 |
Short Previous Month | 1,169 |
Short % of Shares Out | 0.05% |
Short % of Float | 0.07% |
Short Ratio (days to cover) | 1.07 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -668,825 |
Pretax Income | 2.53M |
Net Income | 2.53M |
EBITDA | 2.53M |
EBIT | 2.53M |
Earnings Per Share (EPS) | $0.18 |
Balance Sheet
The company has $60,044 in cash and $62,870 in debt, giving a net cash position of -$2,826 or -$0.00 per share.
Cash & Cash Equivalents | 60,044 |
Total Debt | 62,870 |
Net Cash | -2,826 |
Net Cash Per Share | -$0.00 |
Equity / Book Value | -3.73M |
Book Value Per Share | -0.89 |
Working Capital | -22,560 |
Cash Flow
Operating Cash Flow | -396,175 |
Capital Expenditures | n/a |
Free Cash Flow | -396,175 |
FCF Per Share | -$0.03 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
EUCR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | 6.00% |
FCF Yield | -0.94% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |